• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Nedaplatin

Nedaplatin

Product ID N0212
Cas No. 95734-82-0
Purity ≥98%
Product Unit SizeCostQuantityStock
5 mg $135.10 In stock
10 mg $224.60 In stock
25 mg $428.70 In stock
50 mg $796.10 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Nedaplatin is a second generation platinum compound that exhibits anticancer chemotherapeutic activity. Nedaplatin is a DNA cross-linking agent that acts by binding the N7 position on guanine residues, inhibiting DNA synthesis and repair.

Product Info

Cas No.

95734-82-0

Purity

≥98%

Formula

C2H8N2O3Pt

Formula Wt.

303.18

IUPAC Name

azanide;2-hydroxyacetic acid;platinum(2+)

Melting Point

130°C

Appearance

Off white to pale yellow green powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

N0212 MSDS PDF

Info Sheet

N0212 Info Sheet PDF

References

Yuan G, Wu L, Huang M, et al. A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix. Radiat Oncol. 2014 Feb 18;9:55. PMID: 24533532.

Ali I, Wani WA, Saleem K, et al. Platinum compounds: a hope for future cancer chemotherapy. Anticancer Agents Med Chem. 2013 Feb;13(2):296-306. PMID: 22583420.

Poklar N, Pilch DS, Lippard SJ, et al. Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex. Proc Natl Acad Sci U S A. 1996 Jul 23;93(15):7606-11. PMID: 8755522.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • P0344

    Palbociclib Isethionate

    CDK4/6 inhibitor.

    ≥98%
  • B5875

    Bosutinib, structural isomer

    Bosutinib isomer; Src and Abl inhibitor.

    ≥98%
  • E2003

    Efavirenz

    Non-nucleoside RT inhibitor.

    ≥99%
  • I761004

    Itaconic Acid

    Polymer precursor

    ≥99%
  • M1644

    Meloxicam

    NSAID; COX-2 inhibitor.

    ≥98%
  • M4452

    MLN2480

    Raf inhibitor.

    ≥98%
  • R8076

    Rutin Hydrate

    Flavonoid glycoside found in fruit, asparagus, ...

    ≥95%
  • B030967

    BAY-1895344

    ATR inhibitor.

    ≥99%
  • C0269

    β-Carotene

    Red-orange terpene pigment found in various pla...

    ≥98%
  • J766160

    JTE907

    Selective Cannabinoid receptor 2(CB2) inverse a...

    ≥98%
  • M9644

    Myelin Basic Protein (87-99), guinea pig/human

    Immunodominant peptide epitope occurring in mul...

    ≥95%
  • C0366

    Carvedilol Phosphate Hemihydrate

    FIASMA; α1- and β1/2-adrenergic antagonist.

    ≥98%
  • T3031

    Thienylbutyl Isothiocyanate

    ITC.

    ≥96%
  • G3458

    Ginsenoside Rg1

    Triterpene saponin found in species of Panax.

    ≥98%
  • E4785

    Elvitegravir

    Integrase inhibitor.

    ≥98%
  • P3018

    Phellodendrine

    Quaternary base alkaloid found in Phellodendron...

    ≥98%
  • G124084

    GDC-0973

    MEK1 inhibitor.

    ≥99%
  • K040007

    KB-0742

    CDK9 inhibitor.

    ≥98%
  • C2802

    CH5132799

    p110α PI3K inhibitor.

    ≥98%
  • T9968

    Tyrphostin A25

    SK K+ channel blocker, EGFR inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only